129 related articles for article (PubMed ID: 2663343)
1. The effect of hydroxyethylrutoside and its combination with acetylsalicylic acid in patients with obliterative atherosclerosis.
Roztocil K; Oliva I; Prerovský I; Linhart J
Cor Vasa; 1989; 31(2):128-33. PubMed ID: 2663343
[TBL] [Abstract][Full Text] [Related]
2. The effect of HR (O-Beta-Hydroxyethylo-Rutoside, Venoruton) on the deformability of erythrocytes in patients with arteriosclerosis obliterans of lower limbs.
Lukjan H; Rość D; Chyzy R; Bodzenta A; Szpak A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(1):191-6. PubMed ID: 2581865
[TBL] [Abstract][Full Text] [Related]
3. [Effect of O-(beta-hydroxyethyl)-rutoside (venoruton) on the adherence of leukocytes in patients with arteriosclerosis obliterans of the lower limbs].
Lukjan H; Szpak A; Bodzenta A; Bielawiec M; Rosc D; Chyzy R
Pol Arch Med Wewn; 1985 Jun; 73(6):345-50. PubMed ID: 3880372
[No Abstract] [Full Text] [Related]
4. Clinical effect of O-betahydroxyethyl-rutosides (HR) in patients with occlusive arterial disease.
Bielawiec M; Lukjan H; Grabowski R; Myśliwiec M; Korfel B
Bibl Anat; 1977; (16 Pt 2):152-4. PubMed ID: 603503
[No Abstract] [Full Text] [Related]
5. The effect of O-betahydroxyethyl-rutosides (HR) on the number of platelet-leukocyte aggregates in patients with occlusive arterial disease.
Bielawiec M; Kiersnowska-Rogowska B; Dabrowski S; Lukjan H
Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(1):103-8. PubMed ID: 88383
[TBL] [Abstract][Full Text] [Related]
6. [Venous insufficiency in the pregnant woman. Rheological correction by troxerutin].
Lefebvre G; Lacombe C
Rev Fr Gynecol Obstet; 1991 Feb; 86(2 Pt 2):206-8. PubMed ID: 1767175
[TBL] [Abstract][Full Text] [Related]
7. Hyperaemia of the calf after arterial reconstruction for lower limb atherosclerosis. A study with mercury strain gauge plethysmography.
Kroese A
Acta Chir Scand; 1975; 141(2):104-8. PubMed ID: 1154964
[TBL] [Abstract][Full Text] [Related]
8. Effects of acetylsalicylic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors.
van Wijngaarden J; Smit AJ; de Graeff PA; van Gilst WH; van der Broek SA; van Veldhuisen DJ; Lie KI; Wesseling H
J Cardiovasc Pharmacol; 1994 Feb; 23(2):240-5. PubMed ID: 7511753
[TBL] [Abstract][Full Text] [Related]
9. [Effect of 0-(beta-hydroxyethyl)-rutoside (Venoruton) on symptomatic venous insufficiency in the lower limbs].
Pedersen FM; Hamberg O; Sørensen MD; Neland K
Ugeskr Laeger; 1992 Sep; 154(38):2561-3. PubMed ID: 1413183
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy of troxerutin on the flow properties of blood under defined conditions of circulation. A double-blind study of patients with diabetic retinopathy and arteriosclerotic retinopathy].
Gallasch G; Dörfer C; Schmitt T; Stage A
Klin Monbl Augenheilkd; 1985 Jul; 187(1):30-5. PubMed ID: 3906246
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin I-converting enzyme inhibitor improves reactive hyperemia in elderly hypertensives with arteriosclerosis obliterans.
Okuro M; Morimoto S; Takahashi T; Okaishi K; Nakahashi T; Murai H; Iwai K; Kanda T; Matsumoto M
Hypertens Res; 2006 Sep; 29(9):655-63. PubMed ID: 17249520
[TBL] [Abstract][Full Text] [Related]
12. The effect of pyridinolcarbamate after acute and chronic administration in patients with atherosclerosis obliterans.
Roztocil K; Oliva J; Linhart J; Prerovský I; Modr Z
Int J Clin Pharmacol Biopharm; 1977 Mar; 15(3):135-8. PubMed ID: 844932
[TBL] [Abstract][Full Text] [Related]
13. Clinical effect of high doses of o-betahydroxyethyl-rutosides in patients with occlusive arterial disease.
Bielawiec M; Lukjan H; Kiersnowska-Rogowska B; Dabrowski S
Bibl Anat; 1979; (18):378-81. PubMed ID: 496871
[No Abstract] [Full Text] [Related]
14. Evaluation of the microcirculatory effects of Venoruton in patients with chronic venous hypertension by laserdoppler flowmetry, transcutaneous PO2 and PCO2 measurements, leg volumetry and ambulatory venous pressure measurements.
Belcaro G; Rulo A; Candiani C
Vasa; 1989; 18(2):146-51. PubMed ID: 2662674
[TBL] [Abstract][Full Text] [Related]
15. A double blind three center clinical trial on the short-term efficacy of 0-(beta-hydroxyethyl)-rutosides in patients with post-thrombotic syndrome.
de Jongste AB; Jonker JJ; Huisman MV; ten Cate JW; Azar AJ
Thromb Haemost; 1989 Nov; 62(3):826-9. PubMed ID: 2688186
[TBL] [Abstract][Full Text] [Related]
16. [Benzopyrone in the therapy of postreconstructive edema. A clinical double-blind study].
Becker HM; Niedermaier G; Orend KH
Fortschr Med; 1985 Jun; 103(21):593-6. PubMed ID: 4018687
[No Abstract] [Full Text] [Related]
17. Efficacy of O-(beta-hydroxyethyl)-rutosides at high dosage in counteracting the unwanted activity of oral contraceptives on venous function.
Cappelli R; Pecchi S; Oberhauser V; Forconi S; Di Perri T
Int J Clin Pharmacol Res; 1987; 7(4):291-9. PubMed ID: 3596872
[TBL] [Abstract][Full Text] [Related]
18. [Dosage of O-beta hydroxyethylrutoside in chronic venous insufficiency].
Stemmer R; Furderer CR
Phlebologie; 1986; 39(4):995-1003. PubMed ID: 3562569
[TBL] [Abstract][Full Text] [Related]
19. [Effect of troxerutin on platelet aggregation in patients with arteriosclerosis].
Myśliwiec M; Bodzenta A
Pol Tyg Lek; 1983 Oct; 38(44):1367-8. PubMed ID: 6674961
[No Abstract] [Full Text] [Related]
20. Effects of ketanserin on blood pressure, peripheral circulation and haemocoagulative parameters in essential hypertensives with or without arteriosclerosis obliterans of the lower limbs.
Novo S; Alaimo G; Abrignani MG; Giordano U; Avellone G; Pinto A; Adamo L; Cutietta A; Indovina A; Strano A
Int J Clin Pharmacol Res; 1986; 6(3):199-211. PubMed ID: 2943685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
